A method was introduced to document the progressive changes in the ability of rat skeletal marrow to respond to bleeding over a span of 60 weeks following a single sublethal whole-body x-ray dose. Rats were exposed to a 170-R (200-kVp x-ray) whole-body dose. At intervals of 3, 6, 7, 10, 25, 33, 40, and 60 weeks postirradiation, half of each of the x-irradiated and control groups was bled one-third or two-thirds of the calculated blood volume (cbv) each, and their overall skeletal marrow content of nucleated RBC was determined. The remainder of the x-irradiated and control animals were measured for total marrow content of nucleated RBC without bleeding. The increase in RBC precursors on bleeding in the x-irradiated animal was compared with that found in the control animal on bleeding. This ratio (x-irradiated RBC precursor increase ÷ control RBC precursor increase) constitutes the "erythroid response index" (ERI) and is expressed as a percentage. An ERI value of 100% is taken to mean a lack of residual injury. Any value of ERI less than 100% would then be the percentage of residual injury (residual injury (%) = 100% - ERI). When the residual injury was calculated for the various times studied and plotted, a simple negative exponential function was found between 7 and 60 weeks postirradiation. The loss of residual injury measured in this manner was found to have a half-time of 29.2 weeks.
Skip Nav Destination
Research Article| March 01 1969
A Method for Determining Residual Injury in the Hematopoietic System of the X-Irradiated Rat
T. J. MacVittie ;
Radiat Res (1969) 37 (3): 467–477.
- Views Icon Views
- Share Icon Share
- Search Site
J. K. Gong, T. J. MacVittie, J. E. Vertalino; A Method for Determining Residual Injury in the Hematopoietic System of the X-Irradiated Rat. Radiat Res 1 March 1969; 37 (3): 467–477. doi: https://doi.org/10.2307/3572687
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner